Category: Blog
New Approaches to Digital Platform Governance: Regulatory Analogies (by Ellen P. Goodman)
By Professor Ellen P. Goodman The cockfight between Facebook and Twitter over how to handle political advertising on digital platforms — and the all-too serious consequences — is only the most recent manifestation of western democracies’ failure to regulate digital platforms. There are a number of regulatory proposals and new laws, especially in Europe, to create oversight for … Continue reading New Approaches to Digital Platform Governance: Regulatory Analogies (by Ellen P. Goodman)…
Facebook’s Moment for Thought Leadership on Internet Regulation Has Passed
Professor Ellen P. Goodman It’s no surprise that Mark Zuckerberg has called for “updating the rules for the Internet” – he signaled as much last April in his testimony before the U.S. Senate, inclining his head towards the yoke of regulation. But things have changed significantly since then and Zuckerberg has missed his moment to lead on … Continue reading Facebook’s Moment for Thought Leadership on Internet Regulation Has Passed…
Addressing Abusive Citizen Petitions
“Citizen petitions” filed with the FDA are supposed to raise legitimate safety concerns. But my work has shown that nearly all are filed by brand drug firms and that the FDA denies more than 90 percent of them. The FDA has offered draft guidance to address abusive citizen petitions. My comment applauds this attention and … Continue reading Addressing Abusive Citizen Petitions…
Challenging Deceptive Drug Pricing
Consumers rely on listed prices being accurate. Imagine walking into your favorite store, bringing your desired item to the counter, and being told that the price you had to pay had little relation to the listed price. Remarkable as it is, this is commonplace in the pharmaceutical industry. Minnesota Attorney General Lori Swanson recently filed … Continue reading Challenging Deceptive Drug Pricing…